113 related articles for article (PubMed ID: 2363416)
1. Development of 5q- myelodysplasia in a patient with sarcoidosis.
Tunkel AR; Sebastianelli KJ; Pandit N; Brody JI
Am J Hematol; 1990 Jul; 34(3):225-7. PubMed ID: 2363416
[TBL] [Abstract][Full Text] [Related]
2. Sarcoidosis in a patient with 5q-myelodysplasia. A possible pathogenetic link between the two diseases.
Airaghi L; Montori D; Zorzi F; Miadonna A; Tedeschi A
Monaldi Arch Chest Dis; 2000 Oct; 55(5):378-80. PubMed ID: 11213374
[TBL] [Abstract][Full Text] [Related]
3. Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.
Lewis S; Oscier D; Boultwood J; Ross F; Fitchett M; Rack K; Abrahamson G; Buckle V; Wainscoat JS
Am J Hematol; 1995 Jul; 49(3):194-200. PubMed ID: 7604812
[TBL] [Abstract][Full Text] [Related]
4. Two karyotypically unrelated clones with the t(5;17) and deletion of 5q in myelodysplastic syndrome.
Novak A; Jankovic G; Rolovic Z
Cancer Genet Cytogenet; 1992 Aug; 62(1):100-2. PubMed ID: 1521224
[TBL] [Abstract][Full Text] [Related]
5. Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
Boultwood J; Rack K; Kelly S; Madden J; Sakaguchi AY; Wang LM; Oscier DG; Buckle VJ; Wainscoat JS
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6176-80. PubMed ID: 1829836
[TBL] [Abstract][Full Text] [Related]
6. Unusual findings in two patients with acquired deletions of the long arm of chromosome 5 (5q-).
Lishner M; Amato D; Chalvardjian P; Baker MA; Fernandes B; Pantalony D; Dube ID
Clin Lab Haematol; 1991; 13(1):87-92. PubMed ID: 2060266
[TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic syndrome with partial deletion of the long arm of chromosome 5: first report of a case in a child.
Shikano T; Ishikawa Y; Anakura M
Acta Paediatr Jpn; 1992 Oct; 34(5):539-42. PubMed ID: 1442027
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic and molecular diagnosis of chromosome 5 deletions in myelodysplasia.
Westbrook CA; Hsu WT; Chyna B; Litvak D; Raza A; Horrigan SK
Br J Haematol; 2000 Sep; 110(4):847-55. PubMed ID: 11054067
[TBL] [Abstract][Full Text] [Related]
9. Trisomy 13 in a patient with leukemic progression of myelodysplasia.
Luciano L; Polito P; Catalano L; Selleri C; Alfinito F; Rotoli B
Cancer Genet Cytogenet; 1993 Sep; 69(2):136-8. PubMed ID: 8402552
[TBL] [Abstract][Full Text] [Related]
10. 5q- syndrome terminating in acute myeloid leukemia. Karyotype evolution and immunologic characterization of blast cells.
Donti E; Tabilio A; Donti GV; Mecucci C; Carotti A; Grignani F; Martelli MF
Cancer Genet Cytogenet; 1988 Jun; 32(2):205-9. PubMed ID: 3163260
[TBL] [Abstract][Full Text] [Related]
11. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
[TBL] [Abstract][Full Text] [Related]
13. Rare tetraploidy with large 5q deletion in acute myeloid leukemia with myelodysplasia-related changes (AML-MRC).
Jarosova M; Nedomova R; Hubacek J; Holzerova M; Mickova P; Katrincsakova B; Pikalova Z; Papajik T; Indrak K
Leuk Res; 2012 Apr; 36(4):e68-70. PubMed ID: 22284693
[No Abstract] [Full Text] [Related]
14. Late appearing 5q--marker in refractory anemia.
Heim S; Billström R; Kristoffersson U; Mandahl N; Mitelman F
Cancer Genet Cytogenet; 1987 Jan; 24(1):159-62. PubMed ID: 3466668
[TBL] [Abstract][Full Text] [Related]
15. Outcome following haematopoietic cell transplantation in patients with myelodysplasia and del (5q) karyotypes.
Stewart B; Verdugo M; Guthrie KA; Appelbaum F; Deeg HJ
Br J Haematol; 2003 Dec; 123(5):879-85. PubMed ID: 14632779
[TBL] [Abstract][Full Text] [Related]
16. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
Nimer SD
J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
[TBL] [Abstract][Full Text] [Related]
17. The role of lenalidomide in the management of myelodysplasia with del 5q.
Kelaidi C; Eclache V; Fenaux P
Br J Haematol; 2008 Feb; 140(3):267-78. PubMed ID: 18217896
[TBL] [Abstract][Full Text] [Related]
18. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
Rosati S; Anastasi J; Vardiman J
Semin Hematol; 1996 Apr; 33(2):111-26. PubMed ID: 8722682
[No Abstract] [Full Text] [Related]
19. Clonal monosomy 7 and 5q--in a child with myelodysplastic syndrome.
Chantrain C; Vermylen C; Michaux L; Brichard B; Cornu G
Pediatr Hematol Oncol; 2000 Sep; 17(6):505-9. PubMed ID: 10989472
[TBL] [Abstract][Full Text] [Related]
20. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
